We are live on ! Find out more
BGIM

Boussard & Gavaudan Investment Management Portfolio holdings

AUM $1.06B
1-Year Est. Return 4.58%
This Fund
S&P 500
This Quarter Est. Return
+21.12%
1 Year Est. Return
+4.58%
3 Year Est. Return
+25.82%
5 Year Est. Return
+33.18%
10 Year Est. Return
+356.42%
AUM
$527K
AUM Growth
-$461M
Cap. Flow
-$198M
Cap. Flow %
-37,549.24%
Top 10 Hldgs %
85.67%
Holding
53
New
24
Increased
3
Reduced
3
Closed
11

Top Sells

Rank Stock Value
1
AGN
Allergan plc
AGN
+$204M
2
RTX icon
RTX Corp
RTX
+$62.4M
3
ASH icon
Ashland
ASH
+$16.5M
4
QGEN icon
Qiagen
QGEN
+$11.2M
5
LBRDK icon
Liberty Broadband Class C
LBRDK
+$8.34M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 45.1%
2 Industrials 12.33%
3 Materials 9.37%
4 Financials 6.94%
5 Healthcare 3.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CCXX.U
51
DELISTED
Churchill Capital Corp III Units, each consisting of one share of Class A Common Stock and one-fourt
CCXX.U
-350,000
Closed -$3.5M
AMTD
52
DELISTED
TD Ameritrade Holding Corp
AMTD
-114,973
Closed -$4.09M
AGN
53
DELISTED
Allergan plc
AGN
-1,148,847
Closed -$204M

Similar funds

Boussard & Gavaudan Investment Management's Q2 2020 Portfolio in Review

As of Q2 2020, Boussard & Gavaudan Investment Management held 53 positions worth $527K, down 100% from $461M the previous quarter. Its ten largest holdings account for 86% of the portfolio.

Boussard & Gavaudan Investment Management withdrew a net $198M in Q2 2020, closing 11 positions and reducing 3 holdings. Its most notable exit was Allergan plc, an estimated $204M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 45% of assets, up from 0% a quarter earlier, followed by Industrials and Materials.

Against the trend, Boussard & Gavaudan Investment Management opened a new position in Otis Worldwide worth $14.7K.

  • Boussard & Gavaudan Investment Management's largest Q2 2020 buy was Otis Worldwide: 262,203 shares worth $14.7K.
  • Boussard & Gavaudan Investment Management added most to Tiffany & Co. in Q2 2020, an estimated $36.2M increase.
  • Boussard & Gavaudan Investment Management's biggest Q2 2020 reduction was Qiagen, cutting an estimated $11.2M.
  • Boussard & Gavaudan Investment Management fully exited Allergan plc in Q2 2020, selling an estimated $204M.
  • Boussard & Gavaudan Investment Management's ten largest holdings make up 86% of its $527K portfolio in Q2 2020.
  • Boussard & Gavaudan Investment Management opened 24 new positions and closed 11 in Q2 2020.
  • Boussard & Gavaudan Investment Management's portfolio value fell 100% quarter-over-quarter to $527K.

Based on Boussard & Gavaudan Investment Management's 13F filing for Q2 2020, filed 9 Jul 2020.